PH19734A - Penetrating topical pharmaceutical compositions containing n-(2-hacroxyethyl) pyrrolidone - Google Patents

Penetrating topical pharmaceutical compositions containing n-(2-hacroxyethyl) pyrrolidone

Info

Publication number
PH19734A
PH19734A PH30849A PH30849A PH19734A PH 19734 A PH19734 A PH 19734A PH 30849 A PH30849 A PH 30849A PH 30849 A PH30849 A PH 30849A PH 19734 A PH19734 A PH 19734A
Authority
PH
Philippines
Prior art keywords
hacroxyethyl
pyrrolidone
pharmaceutical compositions
compositions containing
topical pharmaceutical
Prior art date
Application number
PH30849A
Other languages
English (en)
Inventor
Eugene Rex Cooper
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PH19734A publication Critical patent/PH19734A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
PH30849A 1983-06-21 1984-06-20 Penetrating topical pharmaceutical compositions containing n-(2-hacroxyethyl) pyrrolidone PH19734A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/506,273 US4537776A (en) 1983-06-21 1983-06-21 Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone

Publications (1)

Publication Number Publication Date
PH19734A true PH19734A (en) 1986-06-17

Family

ID=24013910

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30849A PH19734A (en) 1983-06-21 1984-06-20 Penetrating topical pharmaceutical compositions containing n-(2-hacroxyethyl) pyrrolidone

Country Status (10)

Country Link
US (1) US4537776A (de)
EP (1) EP0129285B1 (de)
JP (1) JPS6036423A (de)
AU (1) AU559095B2 (de)
CA (1) CA1223818A (de)
DE (1) DE3484573D1 (de)
ES (1) ES8608870A1 (de)
IE (1) IE57602B1 (de)
NZ (1) NZ208383A (de)
PH (1) PH19734A (de)

Families Citing this family (191)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4732892A (en) * 1985-07-12 1988-03-22 American Home Products Corporation L-α-amino acids as transdermal penetration enhancers
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5256647A (en) * 1986-01-31 1993-10-26 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes
US4992422A (en) * 1986-01-31 1991-02-12 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes
AU599964B2 (en) * 1986-01-31 1990-08-02 Nelson Research & Development Company Topical pharmaceuticals dye compositions, and plant nutrient compositions comprising 1-substituted azacycloalkanes as penetration enhancers
ATE84667T1 (de) * 1986-01-31 1993-02-15 Whitby Research Inc Hautpenetration verbessernde zusammensetzungen.
US5142044A (en) * 1986-04-23 1992-08-25 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5041439A (en) * 1986-06-13 1991-08-20 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
ES2042564T3 (es) * 1986-06-13 1993-12-16 Procter & Gamble Composiciones por via topica penetrantes mejoradas para aumentar el crecimiento del cabello.
GB8618259D0 (en) * 1986-07-25 1986-09-03 Leo Pharm Prod Ltd Pharmaceutical compositions
CA1319613C (en) * 1986-10-07 1993-06-29 Gevork Minaskanian Penetration enhancers for transdermal delivery of systemic agents
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
US4959365A (en) * 1986-10-31 1990-09-25 Pfizer Inc. Topical compositions of lipophilic pharmaceuticals agents
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
ES2042527T3 (es) * 1986-11-14 1993-12-16 Theratech Inc Un metodo para preparar una composicion farmaceutica aumentadora de la penetracion para la aplicacion topica.
FR2608044B1 (fr) * 1986-12-10 1992-09-11 Sogeval Composition antibiotique aqueuse a usage veterinaire
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US4879275A (en) * 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
US4920101A (en) * 1987-09-30 1990-04-24 Nelson Research & Development Co. Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
EP0496433B1 (de) 1987-10-22 1999-03-24 The Procter & Gamble Company Chelatbildner enthaltende Lichtschutzmittel
US4946671A (en) * 1987-10-22 1990-08-07 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
US4869897A (en) * 1987-10-22 1989-09-26 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid
US4847069A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
US4954332A (en) * 1987-10-22 1990-09-04 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US4847071A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US4847072A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
US4996199A (en) * 1988-04-08 1991-02-26 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
JP2896898B2 (ja) * 1988-08-24 1999-05-31 富山化学工業株式会社 ピロキシカムのプラスター剤
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5032402A (en) * 1988-10-27 1991-07-16 The University Of Kentucky Research Foundation 3-hydroxy-N-methylpyrrolidone and use as transdermal enhancer
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5008289A (en) * 1988-12-02 1991-04-16 Galenpharma, Inc. Composition for treating nasal disorders and headaches
US4975271A (en) * 1988-12-19 1990-12-04 Vipont Pharmaceutical, Inc. Muscosal delivery systems for treatment of periodontal disease
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5039527A (en) * 1989-02-24 1991-08-13 Medicontrol Corporation Hexamethylmelamine containing parenteral emulsions
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
WO1991002553A2 (en) * 1989-08-17 1991-03-07 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
WO1991008733A1 (en) * 1989-12-20 1991-06-27 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
EP0491076A1 (de) * 1990-12-19 1992-06-24 Theratech, Inc. Penetrationsförderung mittels eines Mehrkomponentensystems aus N-aliphatischen Pyrrolidonen und niederen Alkoholen
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
TW222591B (de) 1991-08-30 1994-04-21 Procter & Gamble
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5506222A (en) * 1991-09-25 1996-04-09 Laboratorios Beta S.A. Method and composition for treating increased androgenic activity
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
WO1995009006A1 (en) * 1993-09-29 1995-04-06 Alza Corporation Monoglyceride/lactate ester permeation enhancer
US5814599A (en) * 1995-08-04 1998-09-29 Massachusetts Insitiute Of Technology Transdermal delivery of encapsulated drugs
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5552153A (en) * 1994-04-28 1996-09-03 Hoffman-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5739156A (en) * 1994-09-21 1998-04-14 The Procter & Gamble Company Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells
US5922758A (en) * 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
US5652256A (en) * 1995-06-06 1997-07-29 Knowles; W. Roy Topical composition for fungal treatment
US6041253A (en) * 1995-12-18 2000-03-21 Massachusetts Institute Of Technology Effect of electric field and ultrasound for transdermal drug delivery
US6002961A (en) * 1995-07-25 1999-12-14 Massachusetts Institute Of Technology Transdermal protein delivery using low-frequency sonophoresis
US5947921A (en) * 1995-12-18 1999-09-07 Massachusetts Institute Of Technology Chemical and physical enhancers and ultrasound for transdermal drug delivery
EP2921111A1 (de) 1995-08-29 2015-09-23 Nitto Denko Corporation Mikroporation der menschlichen Haut zur Arzneimittelabgabe und Überwachungsanwendungen
US5837227A (en) * 1995-12-26 1998-11-17 Hershey Foods Corporation Use of cocoa butter or partially hydrolyzed cocoa butter for the treatment of burns and wounds
US5849729A (en) * 1995-12-26 1998-12-15 Hershey Foods Corporation Use of hydrolyzed cocoa butter for percutaneous absorption
EP0925088A2 (de) 1996-06-28 1999-06-30 Sontra Medical, L.P. Ultraschallsteigerung des transdermalen transports
WO1998000106A1 (en) 1996-07-02 1998-01-08 The Procter & Gamble Company Skin lightening compositions
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
JP4136029B2 (ja) 1997-05-12 2008-08-20 帝國製薬株式会社 硝酸イソソルビド含有貼付剤
DE19725615A1 (de) * 1997-06-17 1998-12-24 Permamed Ag Zur topischen Applikation bestimmte Diclofenac-Lösung
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
US20020006913A1 (en) 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
DK1510213T3 (da) 1997-11-10 2009-03-23 Strakan Int Ltd Penetrationsforbedrende og irritationsreducerende systemer omfattende testosteron
US8287483B2 (en) * 1998-01-08 2012-10-16 Echo Therapeutics, Inc. Method and apparatus for enhancement of transdermal transport
US20060015058A1 (en) * 1998-01-08 2006-01-19 Kellogg Scott C Agents and methods for enhancement of transdermal transport
US7066884B2 (en) 1998-01-08 2006-06-27 Sontra Medical, Inc. System, method, and device for non-invasive body fluid sampling and analysis
AU3217199A (en) * 1998-03-30 1999-10-18 Rutgers, The State University Of New Jersey Antimicrobial protein compounds as novel oral hyperthermic agents for control ofbody weight and hypertension
US6150381A (en) 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor
CA2335976A1 (en) 1998-06-24 1999-12-29 Transderm Diagnostics, Inc. Non-invasive transdermal detection of analytes
DE69943048D1 (de) * 1998-08-18 2011-01-27 Dermtech International San Diego Methode zum nachweis biologischer faktoren in der epidermis
JP2000143540A (ja) * 1998-11-06 2000-05-23 Bristol Myers Squibb Co 非ステロイド系消炎鎮痛薬含有外用剤
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
JP2003506462A (ja) 1999-06-25 2003-02-18 ダーハム ファーマシューティカルズ リミテッド 皮膚浸透剤を含む局所処方物およびその使用
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
CN1304001C (zh) * 1999-07-16 2007-03-14 株式会社昭荣 含有硝基咪唑的皮肤病外用药
US20030078499A1 (en) * 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
US7736661B1 (en) * 2000-03-07 2010-06-15 Avon Products, Inc Method of treating skin conditions
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
KR100856523B1 (ko) 2000-08-03 2008-09-04 안타레스 파르마 아이피엘 에이쥐 충분한 치료효과를 보장하는 활성 화합물의 경피 및/또는경점막 투여용 신규 조성물
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US8728445B2 (en) 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions
US8206738B2 (en) * 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
ATE464887T1 (de) * 2001-05-31 2010-05-15 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
WO2003001985A2 (en) * 2001-06-28 2003-01-09 Dermtech International Method for detection of melanoma
AU2003212962A1 (en) * 2002-02-07 2003-09-02 Massachusetts Institute Of Technology Transdermal drug delivery systems
WO2003101507A2 (en) 2002-03-11 2003-12-11 Altea Therapeutics Corporation Transdermal drug delivery device, method and use
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
US8116860B2 (en) 2002-03-11 2012-02-14 Altea Therapeutics Corporation Transdermal porator and patch system and method for using same
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds
EP1556501A4 (de) 2002-10-28 2009-04-08 Transform Pharmaceuticals Inc Transdermaler assay mit magnetischerklemme
US20050025847A1 (en) * 2003-02-26 2005-02-03 Program For Appropriate Technology In Health Microbicidal compositions and method of use
WO2004105662A1 (en) * 2003-05-23 2004-12-09 Program For Appropriate Technology In Health Microbicidal compositions and methods of use
US20040241223A1 (en) * 2003-05-27 2004-12-02 David Wong Oral dosage forms for macromolecular drugs
JP5619337B2 (ja) 2003-10-10 2014-11-05 フェリング ビー．ブイ． 皮膚残渣を最小限に抑えるための経皮的医薬製剤
US8016811B2 (en) 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
US20070191368A1 (en) * 2004-03-23 2007-08-16 Bissett Donald L Inhibition of tissue damage to skin from radiation treatment therapy
US20050249818A1 (en) * 2004-05-03 2005-11-10 Sawan Samuel P Polycationic antimicrobial therapeutic
EP1802250A4 (de) * 2004-05-07 2008-07-02 Phytotox Ltd Verfahren zur behandlung von wunden mit gonyautoxinen
EP1796676B1 (de) * 2004-05-07 2016-03-09 Phytotox Limited Transdermale verabreichung von phycotoxinen
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
UA93354C2 (ru) 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
US8224414B2 (en) * 2004-10-28 2012-07-17 Echo Therapeutics, Inc. System and method for analyte sampling and analysis with hydrogel
US20060286046A1 (en) * 2005-01-05 2006-12-21 Haber C Andrew Skin care compositions
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US7432069B2 (en) * 2005-12-05 2008-10-07 Sontra Medical Corporation Biocompatible chemically crosslinked hydrogels for glucose sensing
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
US8812071B2 (en) 2007-03-07 2014-08-19 Echo Therapeutics, Inc. Transdermal analyte monitoring systems and methods for analyte detection
US20100210932A1 (en) * 2007-03-20 2010-08-19 Bayer Healthcare Llc Method of analyzing an analyte
NZ580997A (en) 2007-04-27 2011-08-26 Echo Therapeutics Inc Dermal abrasion device with feedback electrode to deliver data on skin thickness and removable abrasion heads
EP2363505A3 (de) * 2007-05-04 2011-12-21 Dermtech International Melanomdiagnose mittels nukleinsäureanalyse
US20090105196A1 (en) * 2007-06-22 2009-04-23 Belinda Tsao Nivaggioli Use of creatine compounds to treat dermatitis
AU2009246180B2 (en) 2008-05-14 2015-11-05 Dermtech International Diagnosis of melanoma and solar lentigo by nucleic acid analysis
US8658699B2 (en) * 2008-05-19 2014-02-25 Massachusetts Institute Of Technology Chemical permeation enhancers enhance nerve blockade by toxins
US8609733B2 (en) * 2008-05-19 2013-12-17 Massachusetts Institute Of Technology Sensory-specific local anesthesia and prolonged duration local anesthesia
JP2012501183A (ja) * 2008-08-28 2012-01-19 ダームテック インターナショナル 皮膚サンプルの年齢範囲の決定方法
WO2010083035A2 (en) 2009-01-14 2010-07-22 Corium International, Inc. Transdermal administration of tamsulosin
US9041541B2 (en) 2010-01-28 2015-05-26 Seventh Sense Biosystems, Inc. Monitoring or feedback systems and methods
US20110105952A1 (en) * 2009-10-30 2011-05-05 Seventh Sense Biosystems, Inc. Relatively small devices applied to the skin, modular systems, and methods of use thereof
US20100256524A1 (en) * 2009-03-02 2010-10-07 Seventh Sense Biosystems, Inc. Techniques and devices associated with blood sampling
WO2010101625A2 (en) 2009-03-02 2010-09-10 Seventh Sense Biosystems, Inc. Oxygen sensor
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
EP2461813A4 (de) 2009-08-05 2014-02-19 Univ Wake Forest Health Sciences Zusammensetzungen und verfahren zur apoptose-herbeiführung in prostatakrebszellen
CA2782441A1 (en) 2009-12-01 2011-06-09 Seprox Biotech, S.L. Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
AU2011264952B2 (en) 2010-06-11 2014-08-14 Quarraisha Abdool Karim Topical antiviral formulations for prevention of transmission of HSV-2
WO2011163347A2 (en) 2010-06-23 2011-12-29 Seventh Sense Biosystems, Inc. Sampling devices and methods involving relatively little pain
JP2013538069A (ja) 2010-07-16 2013-10-10 セブンス センス バイオシステムズ，インコーポレーテッド 流体移動デバイスのための低圧環境
US20130158482A1 (en) 2010-07-26 2013-06-20 Seventh Sense Biosystems, Inc. Rapid delivery and/or receiving of fluids
WO2012021801A2 (en) 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Systems and techniques for monitoring subjects
US8808202B2 (en) 2010-11-09 2014-08-19 Seventh Sense Biosystems, Inc. Systems and interfaces for blood sampling
EP3106092A3 (de) 2011-04-29 2017-03-08 Seventh Sense Biosystems, Inc. Systeme und verfahren zur flüssigkeitsentnahme aus einer person
CN103874460B (zh) 2011-04-29 2016-06-22 第七感生物系统有限公司 一种用于从受验者的皮肤接收血液或其它物质的装置
US20130158468A1 (en) 2011-12-19 2013-06-20 Seventh Sense Biosystems, Inc. Delivering and/or receiving material with respect to a subject surface
EP2701601B1 (de) 2011-04-29 2017-06-07 Seventh Sense Biosystems, Inc. Vorrichtungen und verfahren zur sammlung und/oder manipulation von blutspuren oder anderen körperflüssigkeiten
EP2546358A1 (de) 2011-07-15 2013-01-16 Laboratorios Del. Dr. Esteve, S.A. Verfahren und Reagenzien zur effizienten Steuerung des HIV-Fortschritts
US8853189B2 (en) 2012-05-31 2014-10-07 Prima Innovations, Llc Antispasmodic 1,2-Diols and 1,2,3-triols
NZ710890A (en) 2013-03-15 2016-11-25 Childrens Medical Ct Corp Neosaxitoxin combination formulations for prolonged local anesthesia
CN107148473B (zh) 2014-10-08 2021-08-06 合成生物制品有限公司 β-内酰胺酶制剂及其用途
EP3236993B1 (de) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Verfahren und zusammensetzungen zur hemmung oder verhinderung von unerwünschten wirkungen oraler antibiotika
AU2016229976B2 (en) 2015-03-06 2021-11-11 Theriva Biologics, Inc. Safe and effective beta-lactamase dosing for microbiome protection
WO2017077382A1 (en) 2015-11-06 2017-05-11 Orionis Biosciences Nv Bi-functional chimeric proteins and uses thereof
CN109071632B (zh) 2016-02-05 2022-12-30 奥里尼斯生物科学私人有限公司 靶向性治疗剂及其用途
JP2019507762A (ja) 2016-03-07 2019-03-22 ブイアイビー ブイゼットダブリュー Ｃｄ２０結合単一ドメイン抗体
WO2017194783A1 (en) 2016-05-13 2017-11-16 Orionis Biosciences Nv Targeted mutant interferon-beta and uses thereof
WO2017194782A2 (en) 2016-05-13 2017-11-16 Orionis Biosciences Nv Therapeutic targeting of non-cellular structures
CN110114368B (zh) 2016-10-24 2024-08-02 奥睿尼斯生物科学私人有限公司 靶向突变干扰素-γ及其用途
EP3576765A4 (de) 2017-02-06 2020-12-02 Orionis Biosciences, Inc. Zielgerichtetes manipuliertes interferon und verwendungen davon
CN110546160A (zh) 2017-02-06 2019-12-06 奥里尼斯生物科学公司 靶向嵌合蛋白及其用途
EP3580230A1 (de) 2017-02-07 2019-12-18 VIB vzw Auf immunzellen gerichtete bispezifische chimäre proteine und verwendungen davon
CN110573133A (zh) * 2017-04-11 2019-12-13 宝洁公司 化妆品组合物
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
ES2954714T3 (es) 2017-10-11 2023-11-23 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico para la administración transdérmica de guanfacina que comprende un polímero híbrido acrílico de silicona
KR20200128533A (ko) 2018-02-05 2020-11-13 오리오니스 바이오사이언시즈 인코포레이티드 섬유아세포 결합제 및 이의 용도
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
AU2019224114A1 (en) 2018-02-23 2020-09-10 Finch Therapeutics Holdings Llc Microbiome related immunotherapies
US11578373B2 (en) 2019-03-26 2023-02-14 Dermtech, Inc. Gene classifiers and uses thereof in skin cancers
AU2020316330A1 (en) 2019-07-19 2022-01-06 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
JP2022547330A (ja) 2019-09-13 2022-11-11 フィンチ セラピューティクス ホールディングス エルエルシー 自閉症スペクトラム障害を治療するための組成物および方法
US20240226187A9 (en) 2019-10-18 2024-07-11 Finch Therapeutics Holdings Llc Compositions and Methods for Delivering a Bacterial Metabolite to a Subject
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
TW202140049A (zh) 2020-01-10 2021-11-01 美商芬奇治療控股有限責任公司 用於治療ｂ型肝炎（ｈｂｖ）及ｄ型肝炎（ｈｄｖ）之組合物及方法
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) * 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
GB1133800A (en) * 1966-11-10 1968-11-20 Ici Ltd Pharmaceutical compositions
US3535422A (en) * 1968-03-11 1970-10-20 Stiefel Laboratories Stable benzoyl peroxide composition
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
US4132781A (en) * 1974-12-19 1979-01-02 Nelson Research & Development Company Method for treatment of acne
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
DE2514873C2 (de) * 1975-04-05 1983-12-29 Merck Patent Gmbh, 6100 Darmstadt Salbengrundlage
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
FR2314731A1 (fr) * 1975-06-19 1977-01-14 Nelson Res & Dev Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
US3991203A (en) * 1975-06-19 1976-11-09 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
US4075353A (en) * 1976-06-09 1978-02-21 Dermatologics For Veterinary Medicine, Inc. Process for the treatment of acarid skin infections in animals
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
CA1072009A (en) * 1976-11-12 1980-02-19 Tibor Sipos Potentiated medicaments containing antimicrobial agents
EP0013459A3 (de) * 1979-01-08 1981-05-13 THE PROCTER & GAMBLE COMPANY Topische Anti-Akne-Zusammensetzungen
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US4289764A (en) * 1979-12-04 1981-09-15 Drythanol Ltd. Steroid compositions
US4423040A (en) * 1980-04-04 1983-12-27 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclohexan-2-ones
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4343798A (en) * 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物

Also Published As

Publication number Publication date
IE57602B1 (en) 1993-01-27
NZ208383A (en) 1987-02-20
JPS6036423A (ja) 1985-02-25
IE841556L (en) 1984-12-21
EP0129285B1 (de) 1991-05-15
DE3484573D1 (de) 1991-06-20
EP0129285A2 (de) 1984-12-27
ES8608870A1 (es) 1986-09-01
AU2955884A (en) 1985-01-03
US4537776A (en) 1985-08-27
ES533580A0 (es) 1986-09-01
AU559095B2 (en) 1987-02-19
CA1223818A (en) 1987-07-07
EP0129285A3 (en) 1987-10-21

Similar Documents

Publication Publication Date Title
PH19734A (en) Penetrating topical pharmaceutical compositions containing n-(2-hacroxyethyl) pyrrolidone
PH20235A (en) Penetrating topical pharmaceutical compositions containing 1-dodecylazacycloheptan-2-one
NZ210837A (en) Analgesic compositions containing amides
NZ210838A (en) Analgesic compositions containing amides
IL74726A (en) N-aryl-n-(4-piperidinyl)amides and pharmaceutical compositions containing them
DE3466476D1 (en) External pharmaceutical composition
PH24049A (en) Substituted benzamide derivatives and pharmaceutical compositions containing the same
NZ209759A (en) Pyrrolidinone derivatives and pharmaceutical compositions thereof
GR80293B (en) Pharmaceutical composition
NZ209050A (en) Sulphur-containing compounds and pharmaceutical compositions
IL77138A0 (en) Pharmaceutical compositions containing 1-heteroaryl-4-arylpyrazolin-5-ones
IL79376A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
ZA859731B (en) Pharmaceutical compositions containing tetrahydrobenzthiazoles
IL80232A0 (en) N-substituted diphenylpiperidines,their manufacture and pharmaceutical compositions containing them
NZ209907A (en) Benzenesulphonyl lactams and pharmaceutical compositions
IL70772A0 (en) Pyrrolidinone derivatives,their manufacture and pharmaceutical compositions containing them
GB8417154D0 (en) Pharmaceutical composition
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
IL79980A0 (en) Pharmaceutical composition containing ypsilon-interferon
NZ212336A (en) N-substituted butyramide derivatives and pharmaceutical compositions
IL74140A (en) Substituted n-((amino)alkyl)-1-pyrrolidine,-1-piperidine and-1-homopiperidine-carboxamides and pharmaceutical compositions containing them
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
GB8407735D0 (en) Pharmaceutical composition
SG92592G (en) Pharmaceutical compositions containing azanaphthalenes
IL63217A0 (en) N-(1-allyl-2-pyrrolidinyl-methyl)2-methoxy-4-amino-5-methylsulfamoyl benzamide,its preparation and pharmaceutical compositions containing it